Related Experiment Video
Updated: Jul 12, 2025

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
Published on: February 16, 2024
Gastrointestinal signet ring cell malignancy: current advancement and future prospects
Weiping Hong1, Qingjun Hu1, Yuan Tan2
1Department of Oncology, Guangdong Sanjiu Brain Hospital, 578 Shatai Road, Baiyun District, Guangzhou City, Guangdong Province, China.
Gastrointestinal signet ring cell carcinoma (SRCC) is a rare but aggressive cancer. This review details its unique clinical and molecular features, potential therapeutic targets, and current treatment strategies.
Area of Science:
- Gastroenterology
- Oncology
- Molecular Biology
Background:
- Gastrointestinal cancer is a leading cause of cancer deaths globally.
- Signet ring cell carcinoma (SRCC) is a distinct subtype with unique characteristics compared to adenocarcinomas (ACs).
- Limited comprehensive reviews exist for SRCC, hindering clinical and molecular understanding.
Purpose of the Study:
- To provide a systematic review of gastrointestinal signet ring cell carcinoma (SRCC).
- To consolidate current knowledge on SRCC's clinical and molecular aspects.
- To identify potential therapeutic targets, biomarkers, and treatment strategies for SRCC.
Main Methods:
- Systematic literature review.
- Analysis of clinical data.
- Molecular pathway investigation.
- Review of therapeutic options and formation mechanisms.
Main Results:
- SRCC presents distinct clinical and molecular profiles compared to AC.
- Several potential therapeutic targets and biomarkers have been identified.
- Current treatment options and underlying formation mechanisms are examined.
Conclusions:
- A comprehensive understanding of SRCC's unique features is crucial.
- Further research into targeted therapies and biomarkers is warranted.
- This review serves as a foundational resource for SRCC research and clinical practice.
More Related Videos
10:28Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Abnormal Proliferation
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
Barrett Esophagus-I: Introduction
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...